Government: Page 2
-
TEFCA, Health Tech Ecosystem are complementary data sharing efforts: officials
The Health Technology Ecosystem, which the HHS and CMS launched last summer, could accelerate advancements in data exchange and isn’t in competition with the ASTP's own interoperability project, officials said.
By Emily Olsen • Feb. 13, 2026 -
HHS elevates officials into Kennedy’s inner circle in advance of midterms
The HHS secretary has four new senior advisors to help him “move faster and go further” on his Make America Healthy Again agenda. The appointments preempt the GOP’s midterm messaging push.
By Rebecca Pifer Parduhn • Feb. 13, 2026 -
Lowering drug costs is on Republicans’ minds. Democrats say GOP policies don’t help.
Lawmakers on both sides of the aisle decried the nation’s high drug costs during a House subcommittee hearing last week. Democrats argued Medicaid cuts and lapsed ACA subsidies are worsening the problem.
By Emily Olsen • Feb. 12, 2026 -
CDC moves to cut $600M in grants to Democrat-led states
The cut grants, which were viewed by Healthcare Dive, fund a wide swath of areas including workforce initiatives, STI prevention measures, health equity proposals and others in California, Colorado, Illinois and Minnesota.
By Sydney Halleman • Feb. 11, 2026 -
House Republicans subpoena 8 health insurers over ACA fraud
The subpoenas request additional documents and information from CVS, Centene, Elevance and more, and suggest House Republicans are considering legislation to combat what they view as rampant fraud in the ACA exchanges.
By Rebecca Pifer Parduhn • Feb. 11, 2026 -
FDA refuses to review Moderna’s mRNA flu vaccine
Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was “inconsistent” with prior FDA communications and went against the regulator’s established guidance for flu shots.
By Delilah Alvarado • Feb. 11, 2026 -
CMS proposes sweeping ACA exchange rule
The CMS said the regulation should remove barriers to more affordable health plans like catastrophic coverage, as enrollment on the exchanges falls following the expiration of stronger financial assistance.
By Emily Olsen • Feb. 10, 2026 -
White House’s online service for drug sales debuts with limited impact on prices
Select products from Pfizer, Eli Lilly and others will be sold at a discount, although the lower costs won’t be felt by many Americans whose medications are covered by insurance.
By Jonathan Gardner • Feb. 6, 2026 -
HHS scraps 340B rebate pilot in win for hospitals
The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
By Emily Olsen • Feb. 6, 2026 -
Express Scripts reaches ‘landmark’ settlement with FTC in insulin suit
The agreement includes sweeping changes for Cigna’s PBM, including no longer preferring expensive drugs over cheaper equivalents on standard formularies and reshoring its controversial rebate aggregator.
By Rebecca Pifer Parduhn • Updated Feb. 4, 2026 -
One-quarter of Medicaid doctors don’t actually treat Medicaid patients: study
The new research published in Health Affairs adds to concerns about low physician participation in the safety-net insurance program, especially among mental health practitioners.
By Rebecca Pifer Parduhn • Feb. 4, 2026 -
Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions
The funding package ends a partial government shutdown and enacts several healthcare policies, including preserving telehealth flexibilities in Medicare through 2027.
By Emily Olsen • Feb. 4, 2026 -
Genetic testing takes greater share of Medicare Part B test spending: OIG
Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.
By Susan Kelly • Feb. 4, 2026 -
CMS presses ahead on accelerated Medicare Advantage audits
The agency quietly released a memo updating MA plans on how it’s approaching risk adjustment data validation audits after a Texas judge’s ruling last year threw the expanded reviews into doubt.
By Rebecca Pifer Parduhn • Feb. 4, 2026 -
Telehealth flexibilities, hospital-at-home waivers lapse amid partial government shutdown
The Senate passed a spending package Friday, but the measure is still awaiting House approval. House Speaker Mike Johnson said the partial shutdown should be brief.
By Emily Olsen • Feb. 2, 2026 -
CMS finalizes rule cracking down on Medicaid provider taxes
The rule puts limits on states levying higher taxes on Medicaid businesses. The CMS argues the tax arrangements allow states to shift costs onto the federal government, but providers say they’re integral for covering the cost of care.
By Emily Olsen • Jan. 30, 2026 -
Labor Department wants to strong-arm PBMs into being more transparent with employers
The DOL proposed a rule that would force pharmacy benefit managers to share a broad range of pricing and compensation information with their employer clients, calling it the most significant proposed PBM reform in decades.
By Rebecca Pifer Parduhn • Jan. 30, 2026 -
Medicaid contractors strike deals with CMS to help states execute work requirements
Ten Medicaid systems vendors have agreed to provide low- or no-cost services to states over the next two years. The Trump administration said the agreements would save $600 million.
By Rebecca Pifer Parduhn • Jan. 29, 2026 -
ACA enrollment backslides to 23M in 2026
That’s down 5% from last year. But it’s not the nosedive some market watchers predicted, and a handful of states — notably, Texas — saw robust growth.
By Rebecca Pifer Parduhn • Jan. 28, 2026 -
Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts
Still, the medications in the latest round of negotiations — which now includes Part B drugs given in doctor’s offices — draw very limited revenue from Medicare, an analyst pointed out.
By Jonathan Gardner • Jan. 28, 2026 -
Deep Dive
Health insurers brace for impact in 2026
Profits will start to tick up after reaching trough levels. Washington will play nice. M&A and AI adoption will accelerate. We asked experts to look into their crystal balls on what the coming year means for a beleaguered industry.
By Rebecca Pifer Parduhn • Jan. 28, 2026 -
CMS official defends flat Medicare Advantage rate proposal for 2027
Medicare director Chris Klomp said the Trump administration is “massively” in support of MA as health insurers cry foul over the meager rate update.
By Rebecca Pifer Parduhn • Jan. 27, 2026 -
CMS proposes excluding chart reviews from MA risk scoring in 2027 payment rule
The proposal would eliminate the financial motivation insurers have to mine their members’ charts for additional diagnoses. Regulators also proposed a flat rate update for 2027, prompting anger from insurers.
By Rebecca Pifer Parduhn • Jan. 27, 2026 -
Surprise Billing
No Surprises disputes increasing even as arbiters catch up, CMS says
The agency released new data on independent dispute resolution in the first half of 2025. Roughly 1.2 million cases were filed in that period, mostly by the same private equity-backed providers.
By Rebecca Pifer Parduhn • Jan. 26, 2026 -
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies couldn’t work with competing pharmacy service companies, House Republicans said.
By Rebecca Pifer Parduhn • Jan. 26, 2026